Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Sanofi India Limited (SANOFI) Stock Price & Analysis

18 Followers

SANOFI Stock Chart & Stats

₹3,327.30₹44.45(1.35%)
At close: 3:30 PM GMT+5:30
₹2.75K₹3K₹3.25KAug 17Aug 31Sep 15Sep 28Oct 12Oct 26Nov 9
Day’s Range
INR 3,295.00 - INR 3,338.40
52-Week Range
INR 2,758.30 - INR 4,699.95
Previous Close
INR 3,282.85
Volume
N/A
Average Volume (3M)
2,363
Market Cap
INR 76.63B
Enterprise Value
INR 74.91B
Total Cash (Recent Filing)
INR 2.75B
Total Debt (Recent Filing)
INR 178.00M
Price to Earnings (P/E)
21.0
Beta
0.81
Next Earnings
Feb 25, 2027 (Est.)
EPS Estimate
36.8
Last Dividend Ex-Date
Nov 05, 2026
Dividend Yield
3.70%

Bulls Say, Bears Say

Bulls Say

Very Low Leverage

The exceptionally low debt burden gives Sanofi India substantial financial flexibility and resilience. Limited leverage reduces balance-sheet strain, supports continued investment or shareholder distributions, and leaves the company better positioned to withstand operating volatility over the coming quarters.

Strong Cash Generation

Free cash flow that broadly converts reported earnings demonstrates strong earnings quality and internal funding capacity. The sharp 2025 improvement strengthens the company’s ability to support operations, fund growth initiatives, and maintain capital returns without relying heavily on external financing.

Sustained Profitability

Consistently high operating and net margins indicate that Sanofi India retains meaningful profitability across its pharmaceutical and healthcare activities. This earnings base can provide resilience during uneven revenue periods and supports reinvestment, cash generation, and long-term shareholder returns.

Bears Say

Revenue Contraction

The recent revenue decline and uneven trajectory indicate weakening operating momentum rather than dependable expansion. If this pattern persists, slower sales growth could reduce operating leverage, limit reinvestment capacity, and make it harder for the company to compound earnings over the next several quarters.

Gross Margin Compression

The substantial gross-margin decline reduces the profit retained from each unit of revenue and pressures overall earnings power. Unless margins recover or costs are offset elsewhere, this compression can constrain operating profitability and weaken the durability of future earnings growth.

Volatile Cash Conversion

Volatility in operating cash flow suggests that reported earnings have not converted into cash consistently across periods. Periodic swings can complicate planning, reduce certainty around internally funded investment, and make the company’s cash-generation profile less predictable despite strong 2025 free cash flow.

Sanofi India Limited News

SANOFI FAQ

What was Sanofi India Limited’s price range in the past 12 months?
Sanofi India Limited lowest stock price was ₹2758.30 and its highest was ₹4699.95 in the past 12 months.
What is Sanofi India Limited’s market cap?
Sanofi India Limited’s market cap is ₹76.63B.
When is Sanofi India Limited’s upcoming earnings report date?
Sanofi India Limited’s next earnings report is estimated for Feb 25, 2027 (not yet confirmed), which is in 106 days.
How were Sanofi India Limited’s earnings last quarter?
Sanofi India Limited released its earnings results on Oct 29, 2026. The company reported ₹50.7 earnings per share for the quarter, beating the consensus estimate of ₹44.15 by ₹6.55.
Is Sanofi India Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Sanofi India Limited pay dividends?
Sanofi India Limited pays a semiannual dividend of ₹75 which represents an annual dividend yield of 3.7%. See more information on Sanofi India Limited dividends here
What is Sanofi India Limited’s EPS estimate?
Sanofi India Limited’s EPS estimate is 36.80.
How many shares outstanding does Sanofi India Limited have?
Sanofi India Limited has 23,030,000 shares outstanding.
What happened to Sanofi India Limited’s price movement after its last earnings report?
Sanofi India Limited reported an EPS of ₹50.7 in its last earnings report, beating expectations of ₹44.15. Following the earnings report the stock price went up 6.636%.
Which hedge fund is a major shareholder of Sanofi India Limited?
Currently, no hedge funds are holding shares in IN:SANOFI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology